IGFL2 and gastric cancer: In this case, it was demonstrated that both an increase in miR-802 expression and a decrease in the synthesis of IGFL2-AS1 significantly suppressed the proliferation, migration, and invasion of gastric cancer cells in vitro, while also inhibiting tumor development in vivo.